The National Agency for Food and Drug Administration and Control (NAFDAC) has warned healthcare providers, patients, and the public about the falsification and parallel importation of three batches of a NAFDAC-registered product: Dostinex 0.5mg Tablets. The post Beware of counterfeit Dostinex tablets, NAFDAC warns appeared first on Vanguard News.